MoonLake announces significant improvements with Nanobody(R) sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
In: Thomson Reuters ONE, 2024-03-10
Zeitungsartikel
Zugriff:
(GLOBE NEWSWIRE via COMTEX) -- MoonLake announces significant improvements with Nanobody(R) sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day - Positive [...]
Titel: |
MoonLake announces significant improvements with Nanobody(R) sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
|
---|---|
Zeitschrift: | Thomson Reuters ONE, 2024-03-10 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|